Wells Fargo’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-105,742
| Closed | -$5.4M | – | 7351 |
|
|
2024
Q4 | $5.4M | Buy |
105,742
+2,678
| +3% | +$132K | ﹤0.01% | 2381 |
|
|
2024
Q3 | $4.25M | Buy |
103,064
+9,341
| +10% | +$449K | ﹤0.01% | 2470 |
|
|
2024
Q2 | $4.51M | Sell |
93,723
-8,766
| -9% | -$389K | ﹤0.01% | 2342 |
|
|
2024
Q1 | $4.92M | Buy |
102,489
+6,695
| +7% | +$358K | ﹤0.01% | 2263 |
|
|
2023
Q4 | $6.22M | Buy |
95,794
+1,033
| +1% | +$62.2K | ﹤0.01% | 2056 |
|
|
2023
Q3 | $6.2M | Buy |
94,761
+11,206
| +13% | +$705K | ﹤0.01% | 1952 |
|
|
2023
Q2 | $4.86M | Sell |
83,555
-8,693
| -9% | -$548K | ﹤0.01% | 2173 |
|
|
2023
Q1 | $5.7M | Buy |
92,248
+41,294
| +81% | +$2.48M | ﹤0.01% | 2018 |
|
|
2022
Q4 | $3.24M | Sell |
50,954
-12,210
| -19% | -$885K | ﹤0.01% | 2395 |
|
|
2022
Q3 | $4.59M | Sell |
63,164
-2,634
| -4% | -$196K | ﹤0.01% | 2060 |
|
|
2022
Q2 | $4.47M | Sell |
65,798
-232,217
| -78% | -$16.7M | ﹤0.01% | 2178 |
|
|
2022
Q1 | $27M | Sell |
298,015
-3,061
| -1% | -$251K | 0.01% | 1124 |
|
|
2021
Q4 | $27.5M | Sell |
301,076
-1,541,828
| -84% | -$132M | 0.01% | 1119 |
|
|
2021
Q3 | $149M | Buy |
1,842,904
+153,412
| +9% | +$12.9M | 0.03% | 488 |
|
|
2021
Q2 | $158M | Buy |
1,689,492
+291,145
| +21% | +$28.2M | 0.03% | 468 |
|
|
2021
Q1 | $150M | Buy |
1,398,347
+77,829
| +6% | +$8.08M | 0.03% | 488 |
|
|
2020
Q4 | $115M | Buy |
1,320,518
+818,787
| +163% | +$57.8M | 0.03% | 578 |
|
|
2020
Q3 | $34.6M | Buy |
501,731
+458,765
| +1,068% | +$29.5M | 0.01% | 1062 |
|
|
2020
Q2 | $2.08M | Buy |
+42,966
| New | +$2.05M | ﹤0.01% | 3235 |
|
Other funds holding NARI
SA
TCWM
Wells Fargo's NARI Position: Q1 2025 in Review
Wells Fargo sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 105,742 shares — an estimated $5.4M sold.
Wells Fargo first reported a position in NARI in Q2 2020 and held it in 19 quarters. The position peaked at $158M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.
- Wells Fargo reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Wells Fargo sold 105,742 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $5.4M.
- Wells Fargo first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 19 quarters.
- Wells Fargo's Inari Medical, Inc. Common Stock position peaked at $158M in Q2 2021.
- 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.
Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.